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ABSTRACT
Objectives This study aimed to characterise the exercise 
performed in UK cardiac rehabilitation (CR) and explore 
relationships between exercise dose and changes in 
physiological variables.
Design Observational cohort study.
Setting Outpatient community- based CR in Leeds, UK. 
Rehabilitation sessions were provided twice per week for 
6 weeks.
Participants Sixty patients (45 male/15 female 33–86 
years) were recruited following referral to local outpatient 
CR.
Outcome measures The primary outcome was heart rate 
achieved during exercise sessions. Secondary outcomes 
were measured before and after CR and included 
incremental shuttle walk test (ISWT) distance and speed, 
blood pressure, brachial artery flow- mediated dilatation, 
carotid arterial stiffness and accelerometer- derived 
habitual physical activity behaviours.
Results The mean % of heart rate reserve patients 
exercised at was low and variable at the start of CR 
(42%±16 %) and did not progress by the middle 
(48%±17 %) or end (48%±16 %) of the programme. 
ISWT performance increased following CR (440±150 m 
vs 633±217 m, p<0.001); however, blood pressure, body 
weight, endothelial function, arterial stiffness and habitual 
physical activity behaviours were unchanged following 
6 weeks of CR (p>0.05).
Conclusion Patients in a UK CR cohort exercise at 
intensities that are variable but generally low. The exercise 
dose achieved using this CR format appears inadequate 
to impact markers of health. Attending CR had no effect 
on physical activity behaviours. Strategies to increase the 
dose of exercise patients achieve during CR and influence 
habitual physical activity behaviours may enhance the 
effectiveness of UK CR.
INTRODUCTION
Cardiac rehabilitation (CR) is a multidisci-
plinary intervention for people recovering 
from adverse cardiac events.1 CR services are 
used by over 100 000 patients annually in the 
UK, equating to over 50% of eligible patients, 
with uptake growing in recent years.2 Approx-
imately 80% of this service is delivered as 
supervised exercise rehabilitation typically 
within hospital and community- based centres. 
Recently, the effectiveness of UK CR was 
called into question following the publication 
of the ‘Rehabilitation after myocardial infarc-
tion trial’3 (RAMIT), the largest randomised 
controlled trial (RCT) in the era of modern 
CR. Using a pragmatic design, it observed no 
beneficial impact of participating in outpa-
tient CR on patients’ all- cause mortality, 
cardiovascular morbidity, risk factors, health- 
related quality of life or self- reported daily 
level of physical activity (PA).
In contrast to previous meta- analyses,1 a 
recent Cochrane review of RCTs comparing 
non- participation to participation in CR 
found no effect on all- cause mortality (risk 
ratio=0.96; 95% CI 0.88 to 1.04) and only 
modest effects on cardiovascular mortality 
(risk ratio=0.74; 95% CI 0.64 to 0.86).4 
Comprising ~13% of patients, the outcomes 
of the review were heavily impacted by the 
RAMIT.3 The failure of recent RCTs to support 
the effectiveness of CR5 has caused specu-
lation as to whether potential health gains 
from exercise- based CR have diminished in 
the context of contemporary cardiovascular 
disease (CVD) treatments4 6 and whether 
RCTs represent real- world CR populations.7
The primary therapeutic component of CR 
is exercise training, which mitigates many risk 
Strengths and limitations of this study
 ► The study population reflects a heterogeneous ‘real- 
world’ cohort from multiple centres.
 ► The description of exercise intensities used in this 
study was derived in the same manner as applied 
in standard practice and not from cardiopulmonary 
exercise testing.
 ► The size of the sample cohort was insufficient to 
draw conclusions regarding the impact of exercise 
intensity on short- term outcomes following cardiac 
rehabilitation.
 ► This study may not reflect regional variability in car-
diac rehabilitation practice.
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factors key to secondary CVD prevention when provided 
in a sufficient dose. The strongest prognostic marker in 
patients with coronary artery disease is cardiorespiratory 
fitness,8–10 a biomarker primarily responsive to exercise 
training. A 12%–15% decrease in all- cause mortality has 
been observed per 1 mL/kg/min increase in cardiorespi-
ratory fitness.8 11 Additionally, exercise training in CR can 
improve CVD risk factors such as lipid profiles,12 cardiac 
function/reverse remodelling,13 vascular endothelial 
function,14 arterial stiffness,15 blood pressure16 and body 
composition.17 These exercise studies are varied in terms 
of the durations, frequencies and intensities used within 
their exercise training programme, yet consistently report 
increases in cardiorespiratory fitness alongside other 
health parameters, suggesting that a sufficient treat-
ment dose was achieved. The lack of positive outcomes 
following CR in the RAMIT3 thus appear counterintu-
itive. However, the various effects of exercise training, 
like many treatments, are dose dependent and the dose 
of exercise performed in the RAMIT and its acute phys-
iological effects are unknown. Accordingly, the RAMIT 
results may indicate an underdosage of exercise.18
A potential explanation may relate to a culture of low 
intensity exercise used in UK CR compared with else-
where. There is a paucity of literature reporting charac-
teristics of the exercise therapy actually achieved—not 
simply prescribed—by patients in UK CR or worldwide.19 
Gains in cardiorespiratory fitness in UK cohorts may be 
minimal20 and are lower relative to those in Europe and 
North America (+0.52 vs+1.55 metabolic equivalents),21 
in part related to a lower number of exercise sessions 
performed in UK CR.22 The contribution of exercise 
intensity to these substandard fitness gains following UK 
CR is unclear though there are indications the exercise 
intensity in routine care is quite low.20 In UK CR, with 
limited resource to increase session number or duration, 
the intensity of exercise becomes the predominant medi-
ator of the achievement of an effective dose of exercise. 
The contribution of exercise intensity to these substan-
dard fitness gains following UK CR is unclear. As Savage23 
highlights, those patients who fail to improve cardiore-
spiratory fitness following CR tend to exercise at a lower 
mean intensity. The beneficial effects of exercise- based 
CR on health are not solely attributable to immediate 
gains in fitness. In addition to providing an opportunity 
to address classical cardiovascular risk factors, this short 
period of exercise training may enhance endothelial 
function by ~2%24–26 and facilitate the adoption of a more 
physically active lifestyle in populations with cardiovas-
cular disease.
To further our understanding of the contributions of 
exercise to patient health outcomes following real- world 
CR and contextualise historical findings, it is necessary to 
describe the characteristics of the exercise dose achieved 
by patients. We hypothesised that the intensity of exer-
cise performed by patients undertaking CR in a UK- based 
cohort would be low and that the CR programme would 
not impact short- term health outcomes. Therefore, 
we sought to characterise the exercise undertaken in a 
cohort of UK patients undergoing community- based CR 
and to examine its impact on habitual PA and vascular 
structure and function.
METHODS
Sixty patients (45 male; 15 female) (table 1) were 
recruited following referral to phase III CR within Leeds 
Community Healthcare NHS Trust subsequent to myocar-
dial infarction or elective revascularisation in 2016–2018. 
Patients were recruited prior to CR at four centres, and 
those with arrythmias, heart failure, valvular disease 
or limited mobility were excluded. Written informed 
consent was gained from patients.
Patient and public involvement
Patients or the public were not involved in the design, or 
conduct, or reporting, or dissemination of this research.
Study design
Patients undertook an incremental shuttle walk test,27 
measurements of blood pressure, height and weight with 
Table 1 Patient characteristics
Baseline characteristics (n=60)
Sex (% male) 75
Age (years) 63±12
Height (m) 1.71±0.10
Weight (kg) 81±15
Systolic blood pressure (mm Hg) 128±20
Diastolic blood pressure (mm Hg) 70±10
Diabetic (%) 15%
Cardiac event (%)
  Myocardial infarction 75
  Coronary artery bypass graft 25
  Percutaneous coronary intervention 62
  Myocardial infarction+percutaneous coronary 
intervention
45
  Days since cardiac event 70±31
  Myocardial infarction 75±30
  Coronary artery bypass graft 71±31
  Percutaneous coronary intervention 102±20
  Myocardial infarction+percutaneous coronary 
intervention
69±28
Medication use (%)
  ACE inhibitors 85
  Antiplatelet agents 95
  β-adrenergic antagonists 93
  Statins 89
  Aspirin 100
Data are mean±SD unless otherwise stated.
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the CR team nurses or healthcare assistants prior to the 
start of the CR programme as per usual care. Patients 
underwent a 6- week programme of twice weekly exercise 
sessions and 1 weekly lifestyle education session. Immedi-
ately prior to the second exercise session, vascular assess-
ments of arterial stiffness and endothelial function were 
performed. Habitual PA was assessed over 7 days via accel-
erometery. Exercise intensities were characterised using 
HR monitors in the 2nd (START), 6th or 7th (MID) and 
11th session (END) of CR. Assessment of arterial stiffness 
and endothelial function was repeated on the 11th exer-
cise session after which accelerometery was repeated for 
a further 7 days. A second ISWT was performed, as well 
as measures of blood pressure and weight at a follow- up 
assessment clinic on completion of CR. Any changes in 
medication usage during the study period were recorded.
Physical activity
Advice to increase habitual PA was delivered by an experi-
enced exercise instructor in the form of a 1- hour lecture. 
No formal home- based exercise programme was provided. 
Habitual PA was objectively measured using hip- mounted 
tri- axial accelerometers (ActiGraph GTX3+, Actigraph 
LLC, Florida, USA). Patients were instructed to wear the 
accelerometer for seven consecutive days and complete 
an adjunct wear time log. Accelerometers sampled at 
30 Hz with data collected in 10 s epochs. Sample data were 
then reduced to 60 s epochs for analysis. Wear time anal-
ysis was performed using ActiLife software (ActiLife, Acti-
graph LLC), and a valid period of wear time was defined 
as >4 days of >10 hours of wear. Periods of >60 min of 
consecutive zero readings were considered as non- wear 
time. Activity intensities were assigned using cut points 
based on those validated in a post- CR population28 as light 
(<1800 counts/min), moderate (1800–3799 counts/min) 
and vigorous (≥3800 counts/min). Moderate to vigorous 
PA bouts were defined as continuous periods of >10 min 
with greater than 1800 counts/min. Sedentary bouts were 
defined as periods of valid wear time exceeding 60 min at 
<150 counts/min.
Arterial stiffness
Patients were instructed to arrive early to their session 
following a >4 hour fast and having abstained from 
alcohol ingestion, caffeine ingestion, exercise and vasodi-
lator medication usage for >12 hours. Patients lay supine 
for 10 min before measures were taken and remained in 
this position throughout ultrasound imaging. Measures 
of carotid intima- media thickness and arterial compli-
ance were measured in the right common carotid artery 
by ultrasound (Vivid I, GE Vingmed Ultrasound, Horten, 
Norway) with a 10 MHz probe (9L, GE Vingmed Ultra-
sound, Horten, Norway). Images were recorded for a 
minimum duration of 20 s. Two recordings in the longitu-
dinal axis were taken 2 cm distal to the carotid bulb. Carotid 
intima- media thickness and compliance were calculated 
using automated edge- detection software (Vascular 
Research Tools 6, Medical Imaging Applications- LLC, 
Iowa, USA). Carotid intima- media thickness was derived 
from the average intima- media thickness of the near and 
far carotid wall imaged in anterior and posterior planes.
Compliance was calculated as:
 C = (Dmax − Dmin)/∆P  
where Dmax and Dmin are the mean maxima and minima of 
carotid artery diameter over a 30- s measurement period.
Endothelial function
Following the carotid examination, flow- mediated dila-
tation (FMD) was measured and analysed using duplex 
ultrasound with the same probe with adherence to guide-
lines.29 The probe was placed on the upper arm prox-
imal to a blood pressure cuff placed on the forearm. 
Baseline measures of brachial artery diameter and blood 
flow were taken before inflating the cuff to >50 mm Hg 
above systolic pressure to occlude forearm blood flow for 
5 min. Images were recorded continuously from 30 s prior 
to the release of the cuff and thereafter for 3 min, using 
Doppler ultrasound to record blood flow using an angle 
of insonation of ≤60°. Brachial artery diameter and blood 
flow were analysed using an automated edge- detection 
software (Vascular Research Tools 6). FMD was defined as 
the percentage change in brachial artery diameter from 
baseline to peak dilatation. Shear rates were estimated 
using measures of blood flow obtained using intensity- 
weighted mean velocities. Shear rate was calculated for 
60- s postocclusion as:
 SR = 8 × VTI/D 
where VTI is the velocity time integral of Doppler flow 
and D is brachial artery diameter.
Exercise training
Each CR session consisted of a warm- up, ~24 min of circuit 
training exercise (12 for 2 min each) and a standard cool 
down. All exercise stations were aerobic activities, with 
a mixture of ‘cardiovascular’ stations such as stepping, 
cycling or walking and ‘active recovery’ stations such as 
light dumbbell exercises or supported bodyweight exer-
cises. Sessions were led by specialist exercise instructors 
and adhered to Association of Chartered Physiotherapists 
in Cardiac Rehabilitation guidelines, using a prescribed 
intensity of 40%–70% of heart rate reserve (HRR) and 
a rating of perceived exertion of 2–4 on the Borg CR10 
scale.30 Patients were presented with individualised heart 
rate prescriptions prior to each session on clipboards and 
name badges that were used by the cardiac rehab team 
to monitor exercise intensity. During the three sessions 
where HR was recorded, heart rate monitors were worn 
throughout (Polar RS800CX, Polar Electro, Finland) and 
data outputted in 5 s epochs. Heart rate monitors were 
worn during other sessions as per usual care. Resting 
blood pressures and heart rate were taken manually by 
the nursing team before and after each session as per 
usual practice.
Percentage HRR was calculated as:
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 HRR = (HR − resting HR)/(HRmax − resting HR) 
 HR max = 205.8 − (0.685 × age) 
where HRmax is maximum predicted HR (calculated 
using the Inbar formula). For patients using β-blockers, 
an additional 20 beats/min were subtracted from 
maximal HR.30 31
Incremental shuttle walk test
The ISWT was performed as described by Singh et al27 
with HR monitored via a Polar HR monitor and recorded 
at the end of each minute and on termination of the test. 
The test was terminated when a participant failed to reach 
more than two consecutive shuttles in time, felt unable to 
continue due to breathlessness or completed all twelve 
levels.
STATISTICAL ANALYSIS
Analysis was completed using SPSS (SPSS Statistics for 
Windows, V.24.0). Data were assessed for normal distri-
bution using Shapiro- Wilk, subsequently non- normally 
distributed data were log transformed. Non- parametric 
analyses were performed on variables that remained 
non- normally distributed following transformation. A 
comparison of heart rate data between the three moni-
tored exercise sessions was undertaken as both time spent 
above a series of HRR thresholds and as mean %HRR 
achieved in each session and analysed via Kruskall- 
Wallis, Wilcoxon- signed rank tests and one- way repeated 
measures analysis of variance. Groupings were identified 
as cardiac pathology and comorbidities (hypertension 
and diabetes). Further groupings were created by splitting 
mean heart rates per session into tertiles and by whether 
patients accumulated more than 8 or 12 min above HRR 
thresholds. To assess whether variables changed from 
pre- CR to post- CR, a general linear mixed model was 
used with time, pathology and comorbidity status as fixed 
factors and cardiovascular risk factors (blood pressure, 
weight and resting heart rate), measures of ISWT perfor-
mance, parameters of daily PA and measures of vascular 
endothelial function and arterial stiffness as random 
effects.
Relative FMD was calculated as described elsewhere.32 
To assess whether differences in vascular adaptations with 
training differed by cardiac pathology, these were also 
included within the analysis of covariance model as fixed 
factors.
Pearson’s and Spearman correlations were performed 
to examine relationships between baseline values and 
prechange to postchanges following CR in ISWT perfor-
mance variables, age, blood pressure, habitual PA, endo-
thelial function and arterial stiffness. Alpha level was 
accepted as 0.05 unless stated otherwise. Missing data are 
enumerated in tables 2 and 3, but were excluded from 
statistical analyses.
RESULTS
Patient characteristics
Patient characteristics are displayed in table 1. The 
proportion of males and diabetics in the sample was 
similar to that typically seen in UK CR (70% and 23%33).
In-exercise characteristics
Table 2 displays the mean time per monitored session 
spent above HRR thresholds from 40% to 80%. The 
mean %HRR achieved during the three monitored 
exercise sessions was unchanged (start: 42%±16%, mid: 
48%±17% and end: 48%±16%; p=0.06). Frequencies of 
patients accumulating at least 8 and 12 min above different 
intensities in each exercise session are displayed in table 3. 
The variability in heart rates achieved by patients in the 
START session is shown in figure 1. The progression of 
exercise intensity throughout the programme is displayed 
in figure 2.
The impact of 6 weeks of CR
No changes were observed in assessments of habitual PA, 
endothelial function or arterial stiffness following 6 weeks 
Table 2 Mean time spent above HRR thresholds during 
each measured session
HRR threshold
Time spent above HRR threshold (min)
Start
(n=56)
Mid
(n=49)
End
(n=46)
40% 14.2±11.2 18.9±10.0 18.4±10.3
50% 8.9±10.1 13.1±10.5 12.6±11.1
55% 6.6±9.1 10.0±10.5 9.7±10.5
60% 4.8±8.0 7.5±10.0 7.1±9.1
65% 3.6±7.2 5.5±9.0 5.2±7.8
70% 2.5±5.9 4.1±7.7 3.5±6.2
80% 1.0±3.0 1.9±4.6 1.4±4.2
Data are presented as mean±SD. No differences were observed 
between sessions (p<0.05).
HRR, heart rate reserve.
Table 3 Number of patients in each measured session 
accumulating 8 and 12 min above HRR thresholds
HRR 
threshold
Start
n=56
Mid
n=49
End
n=46
8 min 12 min 8 min 12 min 8 min 12 min
40% 36 31 38 37 34 33
50% 23 19 30 25 25 21
55% 16 13 19 16 21 16
60% 13 10 14 13 16 13
65% 10 6 12 11 12 9
70% 5 5 10 8 7 6
80% 3 2 6 3 3 3
HRR, heart rate reserve.
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of CR (p>0.05: table 4). Following the CR programme, 
ISWT performance increases were seen in peak HR 
(+14%), distance (+44%) and speed (+13%, all p<0.001). 
Changes in walk speed and distance were correlated with 
the increase in peak HR achieved during the test (ρ=0.52; 
p<0.001 and ρ=0.49; p<0.001, respectively).
No adverse events were reported across the course of 
the study.
DISCUSSION
Our data suggest that the dose of exercise achieved by 
patients in an UK outpatient phase III CR programme 
is highly variable and predominantly performed at the 
lower end of the prescribed 40%–70% HRR range. The 
CR programme did not induce a change in measured 
cardiovascular risk factors, habitual PA or markers of 
vascular structure and function. These findings imply that 
patients accumulate an insufficient exercise dose to drive 
improvements in surrogate markers of health, suggesting 
that the current format of UK CR may be suboptimal.
When CR is resource limited, only exercise intensity 
can be manipulated without additional expenditure to 
modify exercise dose. Current UK CR recommendations 
state patients should exercise within the intensity range of 
40%–70% of HRR.30 Patients are asked to achieve these 
intensities using a circuit training style programme. With 
this prescription, our data suggest that most patients typi-
cally exercise around the lower end of this range. Further-
more, only ~30% of patients accumulated 8 min above 
40% HRR (~a third of session duration) early in the 
programme, while 8% of patients failed to ever exceed 
this threshold during the three monitored sessions. The 
mean HR per session was <55% HRR and did not progress 
across the 6- week programme.
Given the dose–response relationship of exercise 
intensity with cardiorespiratory fitness,34 the strongest 
predictor of mortality in patients following CR,8–10 the 
lack of progression in exercise intensity is concerning. 
In exercise training programmes where the volume of 
exercise (frequency and duration) performed is fixed 
or limited by resources, the only method of modifying 
the dose of exercise received is by varying its intensity. A 
meta- regression of RCTs of CR has demonstrated that the 
intensity of exercise training positively influences gains in 
cardiorespiratory fitness.23 35 The pattern of exercise and 
amount of time spent at higher intensities can also have 
independent effects on cardiorespiratory fitness.34 36 37 In 
the present study, we did not detect an association with 
mean exercise intensity or time spent at higher intensities 
and changes in measures of vascular function or struc-
ture or habitual PA. This is partly attributable to the small 
number of our sample that achieved higher training 
intensities, the brief training period compared with 
non- UK cohorts21 and limitations of using HR prediction 
equations to prescribe exercise intensities in CR.38 39
We observed large improvements in ISWT distance 
(+193±14 m), a surrogate measure of exercise capacity, 
following participation in CR. This increase by far exceeds 
the minimally clinically meaningful difference of 70 m40 
and is almost double the improvement seen in a recent 
RCT in a middle- income country41 despite using one- 
third of the total number of sessions. This unexpectedly 
large improvement in ISWT performance likely reflects 
familiarisation42 with the test plus an increase in exercise 
tolerance and/or effort.
PA has a dose–response relationship with CVD risk.43 
Thus, modifying habitual PA following CR is essential as 
both a behavioural outcome contributing to secondary 
CVD prevention and as a driver of health gains. Indices of 
PA were unchanged by the CR programme in the present 
study. A recent systematic review and meta- analysis found 
PA increased with CR participation in only ~25% trials 
assessed.44 As such, targeted and individually- tailored 
behavioural interventions in CR are likely needed 
to increase PA and provide effective secondary CVD 
prevention.45
Figure 1 Mean±SD heart rates throughout the START 
session grouped for those patients who achieved >8 min 
above 55% HRR and those who failed to achieve this. The 
shaded area represents the target heart rate zone. HRR, heart 
rate reserve.
Figure 2 The progression of mean %HRR attainment 
during the across the exercise programme (n=35). Data are 
mean±SD. The shaded area represents the target heart rate 
zone. HRR, heart rate reserve.
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Current attempts to address the impotence of UK CR 
have primarily explored operational factors (patient 
uptake, time since cardiac event, adherence to guide-
lines and provision of additional services).7 However, a 
potential issue with exercise- based CR evaluation is the 
lack of data regarding the achieved, rather than simply 
prescribed, exercise dose.19 This is may explain some of 
the heterogeneity of responses of cardiorespiratory fitness 
to CR in studies with similar exercise prescriptions.46
Our data demonstrate that the application of an exer-
cise prescription identical to that used in the RAMIT can 
result in a highly variable but generally low dose of exer-
cise (figure 2). Furthermore, this intervention does not 
appear adequate to improve vascular health or habitual 
PA: key factors in secondary CVD prevention. Thus, in 
combination with the relatively low total exercise volume 
found in UK CR21 and lack of changes in fitness associ-
ated with it,20 our data displaying low exercise intensi-
ties support the notion that real- world UK CR may not 
currently provide a sufficient exercise dose to improve 
long- term health. These data suggest that poor imple-
mentation of UK CR guidelines may be partly responsible 
for its apparent lack of effectiveness though it cannot rule 
out the possibility that meeting these guidelines is not 
sufficient to provide effective CR. Additionally, the lack of 
fidelity to the exercise prescription in this study calls into 
question the potency of the already considerably variable 
exercise prescriptions across CR trials where the achieved 
exercise intensity is seldom verified.4 As such, future RCTs 
examining CR efficacy should report exercise intensities 
Table 4 Cardiovascular risk factors, ISWT performance, physical activity, endothelial function and arterial stiffness before (pre) 
and after (post) 6 weeks of cardiac rehabilitation
N Pre Post P value
Cardiovascular risk factors
  Weight (kg) 57 81.4±15.4 80.8±15.3 0.82
  Systolic blood pressure (mm Hg) 58 129±20 126±20 0.29
  Diastolic blood pressure (mm Hg) 58 70±10 70±9 0.98
  Resting heart rate (beats/min) 58 64±9 63±10 0.41
ISWT performance
  Distance (m) 59 440±150 633±217 <0.001
  Speed (m/s) 59 1.6±0.3 1.8±0.3 <0.001
  Peak heart rate (beats/min) 53 102±13 116±19 <0.001
Daily physical activity
  Steps 39 6390±2909 6577±3789 0.97
  Sedentary activity (%) 39 41±25 41±25 0.52
  Light activity (%) 39 29±21 28±18 0.92
  Moderate activity (%) 39 4.5±3.2 4.9±4.2 0.75
  Vigorous activity (%) 39 1.3±1.8 1.5±1.9 0.27
  Sedentary activity (min) 39 504±109 485±95 0.93
  Light activity (min) 39 296±90 290±96 0.64
  Moderate activity (min) 39 57±22 61±34 0.09
  Vigorous activity (min) 39 18±18 19±20 0.18
  MVPA (min) 39 75±34 80±45 0.72
  MVPA bout number 39 1.4±1.2 1.6±1.7 0.56
  Time MVPA bouts (min) 39 27±24 31±32 0.29
  Time in sedentary bouts (min) 39 114±87 104±74 0.21
Vascular assessments
  Brachial arterial diameter (mm) 26 4.11±0.71 4.15±0.68 0.78
  Flow- mediated dilatation (%) 25 7.1±4.8 4.9±4.9 0.60
  Shear stress area under the curve 60 s (a.u.) 26 3052±1558 3164±1866 0.68
  Carotid intima- media thickness (mm) 23 0.73±0.11 0.71±0.16 0.39
  Carotid artery compliance
  (mm∙mm Hg∙10-3)
23 9.0±3.9 8.5±3.4 0.32
ISWT, incremental shuttle walk test; MVPA, moderate to vigorous physical activity.  on O
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achieved by patients and investigate the effectiveness of 
higher intensity exercise prescriptions in CR.
Limitations
A shortcoming of this study is the lack of use of cardio-
pulmonary exercise testing to accurately assess changes in 
exercise capacity. Our ability to infer changes in exercise 
capacity from change in ISWT performance may have 
been limited by both a lack of an independent assessor 
or a lack of test familiarisation. The participants recruited 
to this study had a pathology of coronary artery disease; 
thus, this sample does not represent the heterogeneity 
of the wider CR population who are referred with other 
conditions. Due to the nature of performing assessments 
of endothelial function at the remote venues, it was not 
possible to control ambient temperature, lighting or noise 
levels between scans. Additionally, medication use was not 
prohibited prior to these assessments and menstrual cycle 
phase could not be controlled for in females. The small 
number of females included in this study has limited our 
ability to investigate sex and gender- related differences 
in engagement with and responses to routine CR—future 
research into this area is warranted, as is the potential to 
increase female recruitment more generally to CR.
CONCLUSION
The present study has characterised the exercise 
performed by patients in a community- based CR 
programme in the UK. The majority of patients spend 
most of CR at exercise intensities of ~40% of HRR and 
progress little throughout the programme. There was 
an absence of exercise training effects on cardiovascular 
risk factors, measures of endothelial function and arte-
rial stiffness. Habitual PA was unchanged. We recognise 
that the low dose of exercise does not negate the fact that 
there may have been beneficial non- physiological effects 
of CR participation that were not assessed in this study.
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